Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson’s disease by upregulating microRNA-34b-5p and downregulating BACE1

References

• Schneider RB, Iourinets J, Richard IH. Parkinson’s disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag. 2017;7(6):365–376.
   PubMed Web of Science ®Google Scholar
• Beitz JM. Parkinson’s disease: a review. Front Biosci (Schol Ed). 2014;6:65–74.
   PubMedGoogle Scholar
• Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–1272.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.
   PubMed Web of Science ®Google Scholar
• Li J, Meng H, Bai Y, et al. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23(5):205–217..
   PubMed Web of Science ®Google Scholar
• Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–166.
   PubMed Web of Science ®Google Scholar
• Riva P, Ratti A, Venturin M. The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis. Curr Alzheimer Res. 2016;13(11):1219–1231.
   PubMed Web of Science ®Google Scholar
• Liu S, Cui B, Dai Z-X, et al. Long non-coding RNA HOTAIR promotes Parkinson’s disease induced by MPTP through up-regulating the expression of LRRK2. Curr Neurovasc Res. 2016;13(2):115–120..
   PubMed Web of Science ®Google Scholar
• Cao B, Wang T, Qu Q, et al. Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson’s disease via regulating miR-7/NLRP3 pathway. Neuroscience. 2018;388:118–127.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu Q, Zheng S, et al. MicroRNA-21 promotes cell growth and migration by targeting programmed cell death 4 gene in Kazakh’s esophageal squamous cell carcinoma. Dis Markers. 2014;2014:232837.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu L, Shi J, et al. MicroRNA-34b mediates hippocampal astrocyte apoptosis in a rat model of recurrent seizures. BMC Neurosci. 2016;17(1):56..
   PubMed Web of Science ®Google Scholar
• Kabaria S, Choi DC, Chaudhuri AD, et al. Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson’s disease. FEBS Lett. 2015;589(3):319–325..
   PubMed Web of Science ®Google Scholar
• Feng T, Tammineni P, Agrawal C, et al. Autophagy-mediated regulation of BACE1 protein trafficking and degradation. J Biol Chem. 2017;292(5):1679–1690..
   PubMed Web of Science ®Google Scholar
• Koelsch G. BACE1 function and inhibition: implications of intervention in the amyloid pathway of Alzheimer’s disease pathology. Molecules. 2017;22:10.
   Web of Science ®Google Scholar
• Decressac M, Mattsson B, Bjorklund A. Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson’s disease. Exp Neurol. 2012;235(1):306–315.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Coupland KG, Kim WS, Halliday GM, et al. Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein Tau (MAPT) expression in Parkinson’s Disease. PLoS One. 2016;11(6):e0157924..
   PubMed Web of Science ®Google Scholar
• Tarakad A, Jankovic J. Diagnosis and management of Parkinson’s Disease. Semin Neurol. 2017;37(2):118–126.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gu C, Li J, et al. Aberrantly expressed long noncoding RNAs and genes in Parkinson’s disease. Neuropsychiatr Dis Treat. 2018;14:3219–3229.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xing H, Guo S, et al. MicroRNA-135b has a neuroprotective role via targeting of beta-site APP-cleaving enzyme 1. Exp Ther Med. 2016;12(2):809–814..
   PubMed Web of Science ®Google Scholar
• Gong G, An F, Wang Y, et al. miR-15b represses BACE1 expression in sporadic Alzheimer’s disease. Oncotarget. 2017;8(53):91551–91557..
   PubMedGoogle Scholar
• Fang M, Wang J, Zhang X, et al. The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer’s disease. Toxicol Lett. 2012;209(1):94–105..
   PubMed Web of Science ®Google Scholar
• Zeng T, Ni H, Yu Y, et al. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs. J Chem Neuroanat. 2019;98:87–96.
   PubMed Web of Science ®Google Scholar
• Hernandez-Rapp J, Rainone S, Hebert SS. MicroRNAs underlying memory deficits in neurodegenerative disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2017;73:79–86.
   PubMed Web of Science ®Google Scholar
• Knott C, Stern G, Wilkin GP. Inflammatory regulators in Parkinson’s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and −2. Mol Cell Neurosci. 2000;16(6):724–739.
   PubMed Web of Science ®Google Scholar
• Stojkovska I, Wagner BM, Morrison BE. Parkinson’s disease and enhanced inflammatory response. Exp Biol Med (Maywood). 2015;240(11):1387–1395.
   PubMed Web of Science ®Google Scholar
• Pan X, Chen C, Huang J, et al. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson’s disease in rats. Neurosci Lett. 2015;600:220–225.
   PubMed Web of Science ®Google Scholar
• Modarresi F, Faghihi MA, Patel NS, et al. Knockdown of BACE1-AS nonprotein-coding transcript modulates beta-amyloid-related hippocampal neurogenesis. Int J Alzheimers Dis. 2011;2011:929042.
   PubMedGoogle Scholar
• Zhang W, Zhao H, Wu Q, et al. Knockdown of BACE1-AS by siRNA improves memory and learning behaviors in Alzheimer’s disease animal model. Exp Ther Med. 2018;16(3):2080–2086..
   PubMed Web of Science ®Google Scholar
• Yan W, Chen Z-Y, Chen J-Q, et al. LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson’s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun. 2018;496(4):1019–1024..
   PubMed Web of Science ®Google Scholar
• Lin Q, Hou S, Dai Y, et al. LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson’s disease through RAB3IP. Biol Chem. 2018;400(9):1217–1228.
   PubMed Web of Science ®Google Scholar
• Consales C, Cirotti C, Filomeni G, et al. Fifty-Hertz magnetic field affects the epigenetic modulation of the miR-34b/c in neuronal cells. Mol Neurobiol. 2018;55(7):5698–5714..
   PubMed Web of Science ®Google Scholar
• Dong RF, Zhang B, Tai L-W, et al. The neuroprotective role of MiR-124-3p in a 6-hydroxydopamine-induced cell model of Parkinson’s disease via the regulation of ANAX5. J Cell Biochem. 2018;119(1):269–277..
   PubMed Web of Science ®Google Scholar
• Wang H, Ye Y, Zhu Z, et al. MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson’s disease by targeting to bim. Brain Pathol. 2016;26(2):167–176..
   PubMed Web of Science ®Google Scholar